BMS which sells large hepatitis B treatment 'Baraclude' filed a patent infringement prohibition injunction against Daewoong

Published: 2014-08-29 09:36:42

Updated: 2014-08-29 09:53:55

BMS which sells large hepatitis B treatment 'Baraclude' filed a patent infringement prohibition injunction against Daewoong, and it is said that BMS had filed a patent infringement prohibition lawsuit against other pharmaceutical companies which participated in patent invalidity proceedings.

Currently, large number of domestic pharmaceuticals is participating in the patent invalidity proceedin...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.